UnitedHealth Group Incorporated (NYSE:UNH) is Argonautica Private Wealth Management Inc.’s 8th Largest Position

Argonautica Private Wealth Management Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,942 shares of the healthcare conglomerate’s stock after selling 90 shares during the quarter. UnitedHealth Group comprises about 2.1% of Argonautica Private Wealth Management Inc.’s investment portfolio, making the stock its 8th biggest position. Argonautica Private Wealth Management Inc.’s holdings in UnitedHealth Group were worth $6,547,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Fjell Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $857,000. Lingotto Investment Management LLP acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $3,597,000. FFT Wealth Management LLC grew its position in UnitedHealth Group by 13.0% in the fourth quarter. FFT Wealth Management LLC now owns 1,456 shares of the healthcare conglomerate’s stock valued at $736,000 after acquiring an additional 168 shares in the last quarter. Longbow Finance SA lifted its position in shares of UnitedHealth Group by 5.0% during the fourth quarter. Longbow Finance SA now owns 25,150 shares of the healthcare conglomerate’s stock worth $12,722,000 after purchasing an additional 1,191 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. acquired a new stake in UnitedHealth Group during the 4th quarter valued at $228,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 1.9 %

UNH stock opened at $470.49 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $432.99 billion, a PE ratio of 30.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The firm’s 50-day simple moving average is $518.22 and its 200 day simple moving average is $559.08.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The business’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.79%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on UNH shares. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.